23 related articles for article (PubMed ID: 9186300)
1. Associations of Lipoprotein(a) Level with Cerebral Small Vessel Disease in Patients with Alzheimer's Disease.
Chen N; Jiang F; Chen X; Zhu L; Qiao N; Zhou J; Zhang Y
Brain Sci; 2023 Dec; 14(1):. PubMed ID: 38248249
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein lipase-enhanced binding of human triglyceride-rich lipoproteins to heparan sulfate: modulation by apolipoprotein E and apolipoprotein C.
van Barlingen HH; de Jong H; Erkelens DW; de Bruin TW
J Lipid Res; 1996 Apr; 37(4):754-63. PubMed ID: 8732775
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans.
Williams KJ; Fless GM; Petrie KA; Snyder ML; Brocia RW; Swenson TL
J Biol Chem; 1992 Jul; 267(19):13284-92. PubMed ID: 1320015
[TBL] [Abstract][Full Text] [Related]
4. Binding of beta-VLDL to heparan sulfate proteoglycans requires lipoprotein lipase, whereas ApoE only modulates binding affinity.
de Beer F; Hendriks WL; van Vark LC; Kamerling SW; van Dijk KW; Hofker MH; Smelt AH; Havekes LM
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):633-7. PubMed ID: 10073967
[TBL] [Abstract][Full Text] [Related]
5. Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase.
Mulder M; Lombardi P; Jansen H; van Berkel TJ; Frants RR; Havekes LM
J Biol Chem; 1993 May; 268(13):9369-75. PubMed ID: 8387492
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein lipase induces catabolism of normal triglyceride-rich lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycans.
Chappell DA; Fry GL; Waknitz MA; Muhonen LE; Pladet MW; Iverius PH; Strickland DK
J Biol Chem; 1993 Jul; 268(19):14168-75. PubMed ID: 8314783
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E mimetics and cholesterol-lowering properties.
Sharifov OF; Nayyar G; Garber DW; Handattu SP; Mishra VK; Goldberg D; Anantharamaiah GM; Gupta H
Am J Cardiovasc Drugs; 2011 Dec; 11(6):371-81. PubMed ID: 22149316
[TBL] [Abstract][Full Text] [Related]
8. Genetic and Mechanistic Insights into the Modulation of Circulating Lipoprotein (a) Concentration by Apolipoprotein E Isoforms.
Chemello K; Blom DJ; Marais AD; Lambert G; Blanchard V
Curr Atheroscler Rep; 2022 Jun; 24(6):399-405. PubMed ID: 35355214
[TBL] [Abstract][Full Text] [Related]
9. The seventh myth of lipoprotein(a): where and how is it assembled?
Dieplinger H; Utermann G
Curr Opin Lipidol; 1999 Jun; 10(3):275-83. PubMed ID: 10431664
[TBL] [Abstract][Full Text] [Related]
10. Structure and biological activity of heparin.
Casu B
Adv Carbohydr Chem Biochem; 1985; 43():51-134. PubMed ID: 3913287
[No Abstract] [Full Text] [Related]
11. Lipoprotein lipase-enhanced binding of lipoprotein(a) [Lp(a)] to heparan sulfate is improved by apolipoprotein E (apoE) saturation: secretion-capture process of apoE is a possible route for the catabolism of Lp(a).
van Barlingen HH; Kleinveld HA; Erkelens DW; de Bruin TW
Metabolism; 1997 Jun; 46(6):650-5. PubMed ID: 9186300
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
